Annual EBIT
-$9.71 M
+$1.35 M+12.25%
31 December 2023
Summary:
Scinai Immunotherapeutics annual earnings before interest & taxes is currently -$9.71 million, with the most recent change of +$1.35 million (+12.25%) on 31 December 2023. During the last 3 years, it has risen by +$1.16 million (+10.64%). SCNI annual EBIT is now -836.42% below its all-time high of -$279.00 thousand.SCNI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$12.34 M
+$14.37 M+708.73%
01 September 2024
Summary:
Scinai Immunotherapeutics quarterly earnings before interest & taxes is currently $12.34 million, with the most recent change of +$14.37 million (+708.73%) on 01 September 2024. Over the past year, it has increased by +$14.16 million (+776.85%). SCNI quarterly EBIT is now -23.48% below its all-time high of $16.12 million, reached on 01 September 2020.SCNI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$6.56 M
+$14.44 M+183.26%
01 September 2024
Summary:
Scinai Immunotherapeutics TTM earnings before interest & taxes is currently $6.56 million, with the most recent change of +$14.44 million (+183.26%) on 01 September 2024. Over the past year, it has increased by +$16.27 million (+167.60%). SCNI TTM EBIT is now at all-time high.SCNI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +776.9% | +167.6% |
| 3 y3 years | +10.6% | +386.0% | +161.6% |
| 5 y5 years | +64.3% | +187.3% | +127.0% |
SCNI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +12.3% | at high | +386.0% | at high | +153.1% |
| 5 y | 5 years | -836.4% | +64.3% | -23.5% | +187.3% | at high | +125.2% |
| alltime | all time | -836.4% | +64.3% | -23.5% | +187.3% | at high | +125.2% |
Scinai Immunotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.34 M(-708.7%) | $6.56 M(-183.3%) |
| June 2024 | - | -$2.03 M(+5.1%) | -$7.88 M(-6.7%) |
| Mar 2024 | - | -$1.93 M(+5.8%) | -$8.45 M(-13.0%) |
| Dec 2023 | -$9.71 M(-12.3%) | -$1.82 M(-13.3%) | -$9.71 M(-11.0%) |
| Sept 2023 | - | -$2.10 M(-19.0%) | -$10.90 M(-0.5%) |
| June 2023 | - | -$2.60 M(-18.5%) | -$10.96 M(-5.7%) |
| Mar 2023 | - | -$3.19 M(+5.4%) | -$11.63 M(+5.2%) |
| Dec 2022 | -$11.06 M(+1.8%) | -$3.02 M(+39.8%) | -$11.06 M(-10.5%) |
| Sept 2022 | - | -$2.16 M(-33.8%) | -$12.35 M(+1.8%) |
| June 2022 | - | -$3.26 M(+24.8%) | -$12.13 M(+4.6%) |
| Mar 2022 | - | -$2.62 M(-39.4%) | -$11.60 M(+8.9%) |
| Dec 2021 | -$10.86 M(+947.9%) | - | - |
| Dec 2021 | - | -$4.31 M(+122.5%) | -$10.66 M(-26.4%) |
| Sept 2021 | - | -$1.94 M(-29.1%) | -$14.48 M(-504.6%) |
| June 2021 | - | -$2.73 M(+63.8%) | $3.58 M(+117.3%) |
| Mar 2021 | - | -$1.67 M(-79.5%) | $1.65 M(-29.1%) |
| Dec 2020 | -$1.04 M(-96.2%) | -$8.14 M(-150.5%) | $2.32 M(-163.2%) |
| Sept 2020 | - | $16.12 M(-445.5%) | -$3.67 M(-85.4%) |
| June 2020 | - | -$4.67 M(+369.8%) | -$25.18 M(-3.2%) |
| Mar 2020 | - | -$993.40 K(-93.0%) | -$26.03 M(+7.0%) |
| Dec 2019 | -$27.23 M(+38.2%) | -$14.14 M(+162.6%) | -$24.32 M(+28.0%) |
| Sept 2019 | - | -$5.38 M(-2.3%) | -$19.00 M(+33.8%) |
| June 2019 | - | -$5.51 M(-872.1%) | -$14.20 M(-7.3%) |
| Mar 2019 | - | $713.60 K(-108.1%) | -$15.32 M(-22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$19.70 M(+98.1%) | -$8.82 M(+1422.7%) | -$19.63 M(+7.4%) |
| Sept 2018 | - | -$579.40 K(-91.3%) | -$18.27 M(+5.6%) |
| June 2018 | - | -$6.63 M(+84.4%) | -$17.31 M(+51.6%) |
| Mar 2018 | - | -$3.60 M(-51.8%) | -$11.42 M(+32.2%) |
| Dec 2017 | -$9.94 M(+316.4%) | -$7.46 M(-2053.8%) | -$8.64 M(+355.2%) |
| Sept 2017 | - | $381.90 K(-151.5%) | -$1.90 M(-32.9%) |
| June 2017 | - | -$741.50 K(-9.2%) | -$2.83 M(+2.4%) |
| Mar 2017 | - | -$816.90 K(+13.3%) | -$2.76 M(+19.9%) |
| Dec 2016 | -$2.39 M(-17.5%) | -$721.30 K(+31.1%) | -$2.31 M(-15.3%) |
| Sept 2016 | - | -$550.00 K(-18.7%) | -$2.72 M(+27.4%) |
| June 2016 | - | -$676.40 K(+89.0%) | -$2.14 M(-7.5%) |
| Mar 2016 | - | -$357.90 K(-68.5%) | -$2.31 M(-4.2%) |
| Dec 2015 | -$2.90 M(+38.5%) | -$1.14 M(-3309.9%) | -$2.41 M(+38.3%) |
| Sept 2015 | - | $35.40 K(-104.2%) | -$1.74 M(-23.1%) |
| June 2015 | - | -$849.30 K(+85.0%) | -$2.26 M(+10.8%) |
| Mar 2015 | - | -$459.20 K(-2.1%) | -$2.04 M(-4.7%) |
| Dec 2014 | -$2.09 M(-4.7%) | -$468.90 K(-3.7%) | -$2.15 M(-6.0%) |
| Sept 2014 | - | -$486.80 K(-22.7%) | -$2.28 M(-1.8%) |
| June 2014 | - | -$629.50 K(+12.4%) | -$2.32 M(+37.2%) |
| Mar 2014 | - | -$560.30 K(-7.3%) | -$1.69 M(+49.4%) |
| Dec 2013 | -$2.19 M(-10.3%) | -$604.70 K(+14.2%) | -$1.13 M(+114.2%) |
| Sept 2013 | - | -$529.40 K | -$529.40 K |
| Dec 2012 | -$2.44 M(+22.0%) | - | - |
| Dec 2011 | -$2.00 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly EBIT year-on-year change?
- What is Scinai Immunotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM EBIT year-on-year change?
What is Scinai Immunotherapeutics annual earnings before interest & taxes?
The current annual EBIT of SCNI is -$9.71 M
What is the all time high annual EBIT for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual earnings before interest & taxes is -$279.00 K
What is Scinai Immunotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SCNI is $12.34 M
What is the all time high quarterly EBIT for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly earnings before interest & taxes is $16.12 M
What is Scinai Immunotherapeutics quarterly EBIT year-on-year change?
Over the past year, SCNI quarterly earnings before interest & taxes has changed by +$14.16 M (+776.85%)
What is Scinai Immunotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SCNI is $6.56 M
What is the all time high TTM EBIT for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM earnings before interest & taxes is $6.56 M
What is Scinai Immunotherapeutics TTM EBIT year-on-year change?
Over the past year, SCNI TTM earnings before interest & taxes has changed by +$16.27 M (+167.60%)